Presentation and reports of past research periods

 

Overall, almost 1.2 million euros were used for glioblastoma research in the first two funding periods. In both funding periods, three projects were supported. Regular reports to the scientific council and the foundation board were made by the research teams.

26.09.2013 – 31.01.2015

Prof. Dr. Glass (LMU Munich): "Mesenchymal stem cells modulate glioma progression."

» Report Prof. Dr. Glass 

(only available in German)

Prof. Dr. Lamszus (Hamburg): "Importance of brain tumor metabolism for the interaction between tumor cells and brain tissue."

» Report Prof. Dr. Lamszus

(only available in German)

Prof. Dr. Herold-Mende (Heidelberg): "Immunological changes and adaptation of the tumor environment in the course of glioblastoma progression."

» Report Prof. Dr. Herold-Mende 

(only available in German)




01.01.2016 – 31.12.2017

Prof. Dr. Glass: "Tumor-associated mesenchymal stem cells - target of new treatment strategies for glioblastomas"

» Report Prof. Dr. Glass 

(only available in German)

Prof. Dr. Lamszus: "Tumor metabolism - interaction between tumor cells and brain tissue"

» Report Prof. Dr. Lamszus

(only available in German)

Prof. Dr. Herold-Mende: "Immunological changes and adaptation of the tumor environment in the course of glioblastoma progression"

» Report Prof. Dr. Herold-Mende 

(only available in German)




01.01.2018 – 31.12.2019

Prof. Dr. Glass: "New pericytes in brain tumor blood-vessels originate from a previously unrecognized pericyte progenitor"

» Report Prof. Dr. Glass

Prof. Dr. Lamszus: "Identification of immunosuppressive mechanisms in glioblastomas and their evaluation as therapeutic targets"

» Report Prof. Dr. Lamszus

Prof. Dr. Herold-Mende: "Therapeutic application of T cell targets and TAM inhibitors"

» Report Prof. Dr. Herold-Mende

(only available in German)